Xamoterol--a beta-1-adrenoceptor partial agonist. Pharmacology and clinical use
Sørensen, E.V.
Danish Medical Bulletin 40(1): 111-121
1993
ISSN/ISBN: 0907-8916 PMID: 8472594 Document Number: 405386
Document emailed within 1 workday
Related Documents
Wirtzfeld, A.; Klein, G.; Bibra, H.V.; Sauer, E. 1985: Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity? International Journal of Clinical Pharmacology Therapy and Toxicology 23(1): 20-27Kazanietz, M.G.; Enero, M.A. 1990: Desensitization of the beta-2 adrenoceptor-mediated vasodilation in rat aorta after prolonged treatment with the beta-2 adrenoceptor agonist clenbuterol Journal of Pharmacology and Experimental Therapeutics 252(2): 758-764
Shanks, R.G. 1981: Review of a review. Partial agonist activity of beta-adrenoceptor blocking drugs European Heart Journal 2(3): 253-255
Silke, B.; Hanratty, C.G.; Riddell, J.G. 1999: Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods Journal of Cardiovascular Pharmacology 33(6): 859-867
Oriowo, M.A.; Chapman, H.; Kirkham, D.M.; Sennitt, M.V.; Ruffolo, R.R.; Cawthorne, M.A. 1996: The selectivity in vitro of the stereoisomers of the beta-3 adrenoceptor agonist BRL 37344 Journal of Pharmacology and Experimental Therapeutics 277(1): 22-27
Marlin, G.E.; Berend, N.; Harrison, A.C. 1979: Combined cholinergic antagonist and beta 2-adrenoceptor agonist bronchodilator therapy by inhalation Australian and New Zealand Journal of Medicine 9(5): 511-514
Gross, D.M.; Fisher, J.W. 1978: Effects of terbutaline, a synthetic beta adrenoceptor agonist, on in vivo erythropoietin production Archives Internationales de Pharmacodynamie et de Therapie 236(2): 192-201
Canepa-Anson, R.; Dawson, J.R.; Frankl, W.S.; Kuan, P.; Sutton, G.C.; Reuben, S.; Poole-Wilson, P.A. 1982: Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmias European Heart Journal 3 Suppl D: 129-134
Keith, R.A.; Hwang, T.F.; Murthy, V.S.; Kau, S.T.; Salama, A.I.; Giles, R.E. 1989: ICi 147,798: a slowly dissociable beta adrenoceptor antagonist that causes insurmountable beta-1 and surmountable beta-2 adrenoceptor antagonism in isolated tissues Journal of Pharmacology and Experimental Therapeutics 248(1): 240-248
Hamilton, T.C.; Parkes, M.W. 1977: Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2: pharmacology Arzneimittel-Forschung 27(7): 1410-1417
Maccarrone, C.; Malta, E.; Raper, C. 1985: Comparison of the Arrhythmogenic Actions of (-)-Isoprenaline, Dobutamine and the selective beta 1-adrenoceptor agonist, (+/-)-(1-[3',4'-dihydroxyphenoxy] -2-hydroxy-[3",4"-dimethoxy phenethylamino]-propane)-oxalate (Ro 363) Arzneimittel-Forschung 35(3): 592-598
Hedberg, A.; Mattsson, H. 1981: Beta adrenoceptor interaction of full and partial agonists in the cat heart and soleus muscle Journal of Pharmacology and Experimental Therapeutics 219(3): 798-808
Buist, R.A.; Williams, L.R.; Cairncross, K.D. 1974: Pharmacology of sympathomimetic amines with beta-adrenoreceptor agonist and alpha-adrenoreceptor antagonist properties Archives Internationales de Pharmacodynamie et de Therapie 209(2): 227-236
Takayanagi, I.; Koike, K.; Ogishima, M. 1989: Interactions of R(+) and S(-) isomers of befunolol, a partial agonist with high and low affinity sites of beta-adrenoceptors in guinea-pig taenia caecum Archives Internationales de Pharmacodynamie et de Therapie 300: 76-84
Sienra Monge, J.J.; Bermejo Guevara, M.A.; del Río Navarro, B.E.; Rosas Vargas, M.A.; Reyes Ruiz, N.I. 2000: Degree and duration of bronchodilatation with an agonist beta 2 administered alone versus an agonist beta 2 administered with ipratropium bromide in children with acute asthma Revista Alergia Mexico 47(1): 26-29
Dawson, J.R.; Bayliss, J.; Norell, M.S.; Canepa-Anson, R.; Kuan, P.; Reuben, S.; Poole-Wilson, P.A.; Sutton, G.C. 1982: Clinical studies with beta 2 adrenoceptor agonists in heart failure European Heart Journal 3 Suppl D: 135-141
Saran, R.K.; Ahuja, R.C.; Gupta, N.N. 1980: Paradoxical use of an alpha adrenoceptor agonist (methoxamine) an an antihypertensive Journal of the Association of Physicians of India 28(1-2): 39-43
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Tomov, L.; Elenkova, A.; Nikolov, G.T. 1978: Beta-blockaders. their pharmacology and clinical use Vutreshni Bolesti 17(5): 1-12
Piascik, M.T.; Butler, B.T.; Pruitt, T.A.; Kusiak, J.W. 1990: Agonist interaction with alkylation-sensitive and -resistant alpha-1 adrenoceptor subtypes Journal of Pharmacology and Experimental Therapeutics 254(3): 982-991